October 20, 2020
Sawai Pharmaceutical will roll out a generic version of GlaxoSmithKline’s androgenetic alopecia (AGA) treatment Zagallo (dutasteride) on November 6. Dutasteride Capsules 0.5 mg ZA “Sawai” was approved on October 5. There will be no health coverage for the drug, which...read more